S, C., X, C., C, Z., Y, F., C, S., J, W., . . . W, F. (2026). NME3 promotes clear cell renal cell carcinoma progression and modulates TKI response through MFN1/2-dependent mitochondrial fusion and mitophagy suppression. Oncogene. https://doi.org/10.1038/s41388-026-03892-9
Chicago Style (17th ed.) CitationS, Cao, et al. "NME3 Promotes Clear Cell Renal Cell Carcinoma Progression and Modulates TKI Response Through MFN1/2-dependent Mitochondrial Fusion and Mitophagy Suppression." Oncogene 2026. https://doi.org/10.1038/s41388-026-03892-9.
MLA (9th ed.) CitationS, Cao, et al. "NME3 Promotes Clear Cell Renal Cell Carcinoma Progression and Modulates TKI Response Through MFN1/2-dependent Mitochondrial Fusion and Mitophagy Suppression." Oncogene, 2026, https://doi.org/10.1038/s41388-026-03892-9.